UPDATE - YourUpdateTV Speaks with Alanna Morris-Simon from Bayer to Discuss Key Risk Factors for Heart Disease and Resources That Can Help
February 27, 2025 11:51 ET
|
D S Simon
February is American Heart Month - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- ...
YourUpdateTV Speaks with Alanna Morris-Simon from Bayer to Discuss Key Risk Factors for Heart Disease and Resources That Can Help
February 24, 2025 10:34 ET
|
D S Simon
February is American Heart Month - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) --...
Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer’s Disease
February 11, 2025 09:15 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
January 08, 2025 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
December 17, 2024 07:00 ET
|
Tiziana Life Sciences Ltd.
NEW YORK, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
[Latest] Global Injectable Drug Delivery Devices Market Size/Share Worth USD 40,956.3 Million by 2033 at a 10.21% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 25, 2024 11:30 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Injectable Drug Delivery Devices Market Size, Trends and Insights By Device Type...
Syncell’s Microscoop Winner of BioTech Breakthrough Award For “Proteomics Solution of the Year”
November 21, 2024 20:16 ET
|
BioTech Breakthrough
TAIPEI, Taiwan and WATERTOWN, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, today announced that...
[Latest] Global Cancer Cell Analysis Market Size/Share Worth USD 23.31 Billion by 2033 at a 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
November 06, 2024 13:00 ET
|
Custom Market Insights
Austin, TX, USA, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Cell Analysis Market Size, Trends and Insights By Application (Cancer...
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
November 04, 2024 07:30 ET
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
September 24, 2024 08:00 ET
|
Barinthus Biotherapeutics
Barinthus Bio Initiates Phase 1 Clinical Trial of VTP-1000 for the Treatment of Celiac Disease